Long-term efficacy and safety of a third-line treatment with eribulin plus trastuzumab in a young breast cancer patient.
about
Long-term efficacy and safety of a third-line treatment with eribulin plus trastuzumab in a young breast cancer patient.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Long-term efficacy and safety ...... a young breast cancer patient.
@en
Long-term efficacy and safety ...... a young breast cancer patient.
@nl
type
label
Long-term efficacy and safety ...... a young breast cancer patient.
@en
Long-term efficacy and safety ...... a young breast cancer patient.
@nl
prefLabel
Long-term efficacy and safety ...... a young breast cancer patient.
@en
Long-term efficacy and safety ...... a young breast cancer patient.
@nl
P2860
P356
P1433
P1476
Long-term efficacy and safety ...... a young breast cancer patient.
@en
P2093
Claudio Scavelli
Federica Gallù
P2860
P304
P356
10.2217/FON.14.134
P407
P577
2014-11-01T00:00:00Z